Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome

Article

Abstract: Purpose: Myeloma is a clonal malignancy of plasma cells. Poor-prognosis risk is currently identified

Palabras claves:

Autores:

Boyd K.D., Brito J.L., Davies F.E., Dickens N.J., Gonzalez D., Gregory W.M., Jenner M.W., Johnson D.C., Morgan G.J., Paola E. Leone, Ross F.M., Walker B.A., Zeisig A.

Fuentes:

google

scopus